Literature DB >> 33862418

Anti-GM1 IgM antibody positive axonal variant of Guillain-Barre-syndrome in a pediatric patient with dengue fever.

Mario B Prado1, Karla M Narito2, Karen Joy B Adiao3.   

Abstract

INTRODUCTION: While children of all ages may be affected by Guillain-Barre-Syndrome (GBS), there are no reports of Dengue Fever (DF) as the preceding or concurrent infection in this age group. In addition, the presence of anti-GM1 IgM antibody, commonly seen in Multifocal Motor Neuropathy, is rarely encountered in both axonal and demyelinating variants of GBS. Moreover, only few neuromuscular ultrasound findings of the axonal variant in children were reported in the literature. CASE: Here we present a nine-year-old female who developed the classic signs, symptoms and neurophysiologic findings of axonal type of GBS during DF. She had elevated anti-GM1 IgM antibody atypical of this variant and diffusely enlarged nerves via neuromuscular ultrasound.
CONCLUSION: In a pediatric patient with DF and acute flaccid paralysis, GBS should always be one of the considerations. Although rare, anti-ganglioside GM1 IgM antibody can still be found in axonal variant of GBS.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-GM1 IgM antibody; Axonal variant of Guillain Barre syndrome; Dengue fever; Neuromuscular ultrasound; Pediatric patient

Year:  2021        PMID: 33862418     DOI: 10.1016/j.jneuroim.2021.577572

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

1.  Facial Diplegia as the Sole Manifestation of Post-Vaccination Guillain-Barre Syndrome: A Case Report and Literature Review.

Authors:  Mario B Prado; Karen Joy B Adiao
Journal:  Neurohospitalist       Date:  2022-04-23

Review 2.  Nervous System Manifestations of Arboviral Infections.

Authors:  Lakshmi Chauhan; Elizabeth Matthews; Amanda L Piquet; Andrés Henao-Martinez; Carlos Franco-Paredes; Kenneth L Tyler; David Beckham; Daniel M Pastula
Journal:  Curr Trop Med Rep       Date:  2022-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.